Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.695 USD | -2.85% | +10.29% | -40.86% |
May. 14 | Vincerx Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 26 | Tech Rally Boosts Exchange-Traded Funds, Equity Futures Pre-Bell Friday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.86% | 21.13M | |
+18.37% | 125B | |
+14.77% | 108B | |
-6.77% | 23.64B | |
+2.39% | 22.39B | |
-12.11% | 17.78B | |
-41.64% | 16.43B | |
-13.96% | 16.34B | |
-0.02% | 13.56B | |
+25.10% | 11.59B |
- Stock Market
- Equities
- VINC Stock
- News Vincerx Pharma, Inc.
- Vincerx Pharma : Chardan Adjusts Price Target on Vincerx to $30 From $33, Citing 'Forward OpEx Estimates, Recent Dilution;' Buy Rating Kept